What are the potential health consequences of hypertriglyceridemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Health Consequences of Hypertriglyceridemia

Hypertriglyceridemia can cause acute pancreatitis when levels are severely elevated (≥500 mg/dL) and increases cardiovascular disease risk even at moderate levels (≥150 mg/dL). 1

Classification and Risk Stratification

Hypertriglyceridemia is classified based on fasting serum triglyceride levels:

  • Mild: 150-199 mg/dL (1.7-2.3 mmol/L) 1
  • Moderate: 200-999 mg/dL (2.3-11.3 mmol/L) 1
  • Severe: 1,000-1,999 mg/dL (11.3-22.6 mmol/L) 1
  • Very severe: ≥2,000 mg/dL (≥22.6 mmol/L) 1

Major Health Consequences

Acute Pancreatitis

  • Severe (≥1,000 mg/dL) and very severe (≥2,000 mg/dL) hypertriglyceridemia significantly increase the risk of acute pancreatitis 1
  • While hypertriglyceridemia is responsible for only about 9% of all pancreatitis cases, patients with severe hypertriglyceridemia have a 14% incidence of acute pancreatitis 1
  • The risk threshold is not precisely defined, but levels ≥1,000 mg/dL are generally associated with increased pancreatitis risk 1

Cardiovascular Disease

  • Mild to moderate hypertriglyceridemia (150-499 mg/dL) serves as a risk factor for cardiovascular disease 1
  • Elevated triglycerides are associated with atherogenic remnant lipoprotein particles and apolipoprotein CIII-enriched particles that contribute to atherosclerosis 1
  • Hypertriglyceridemia often coexists with other cardiovascular risk factors including low HDL-C, central obesity, and insulin resistance 1
  • Even when not directly causal, elevated triglycerides serve as a marker for cardiovascular disease risk 1

Other Vascular Complications

  • Severe hypertriglyceridemia with chylomicronemia can lead to retinal thrombosis 1
  • In rare cases, it may cause blindness 1

Metabolic Abnormalities

  • Hypertriglyceridemia serves as a biomarker for:
    • Visceral adiposity 1
    • Insulin resistance 1
    • Type 2 diabetes mellitus 1
    • Non-alcoholic hepatic steatosis (fatty liver) 1
  • High triglyceride levels can predict the development of type 2 diabetes, even in individuals with normal or impaired fasting glucose 1

Lipid Abnormalities

  • Often associated with low HDL-cholesterol levels 2, 3
  • May be accompanied by small, dense LDL particles that are more atherogenic 1
  • Contributes to overall dyslipidemia pattern that increases cardiovascular risk 1

Risk Factors and Associated Conditions

Hypertriglyceridemia is frequently associated with:

  • Obesity and overweight 1
  • Physical inactivity 1
  • Excessive alcohol intake 1
  • Metabolic syndrome 1
  • Type 2 diabetes mellitus 1
  • Genetic disorders (familial hypertriglyceridemia, familial combined hyperlipidemia, familial dysbetalipoproteinemia) 1
  • Certain medications (thiazides, beta blockers, estrogen, isotretinoin, corticosteroids, bile acid-binding resins, antiretroviral protease inhibitors, immunosuppressants, antipsychotics) 1
  • Endocrine conditions, renal disease, liver disease, pregnancy, and autoimmune disorders 1

Clinical Implications

  • Patients with elevated triglycerides should be evaluated for secondary causes and treated accordingly 1
  • Those with primary hypertriglyceridemia should be assessed for family history of dyslipidemia and cardiovascular disease 1
  • Evaluation should include assessment for other cardiovascular risk factors such as central obesity, hypertension, abnormal glucose metabolism, and liver dysfunction 1
  • Management strategies differ based on triglyceride levels, with prevention of pancreatitis being the primary goal for severe hypertriglyceridemia and cardiovascular risk reduction for mild to moderate hypertriglyceridemia 1

In summary, hypertriglyceridemia represents a significant health concern with consequences ranging from acute pancreatitis at severely elevated levels to increased cardiovascular risk at more moderate levels, while also serving as a marker for underlying metabolic abnormalities.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypertriglyceridemia.

Journal of the American Board of Family Medicine : JABFM, 2006

Research

Hypertriglyceridemia: its etiology, effects and treatment.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.